Pradžia › Nutukimas › New York › Rochester
Nutukimas klinikiniai tyrimai Rochester, NY
14 tyrimai dėl Nutukimas ieško dalyvių vietose Rochester ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Renkami dalyviai2 fazė
- Rochester Clinical Research /ID# 282484, Rochester
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Renkami dalyviai2 fazė
- Rochester Clinical Research, Rochester
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Renkami dalyviai3 fazė
- Rochester Clinical Research, LLC, Rochester
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Renkami dalyviai3 fazė
- Rochester Clinical Research, Rochester
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Renkami dalyviai3 fazė
- Rochester Clinical Research, LLC, Rochester
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Renkami dalyviai3 fazė
- Rochester Clinical Research, LLC, Rochester
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Renkami dalyviai2 fazė
- Rochester Clinical Research, LLC, Rochester
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Renkami dalyviai2 fazė
- Rochester Clinical Research, LLC, Rochester
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Renkami dalyviai3 fazė
- Rochester Clinical Research, Rochester
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Renkami dalyviai3 fazė
- Kailera Clinical Site, Rochester
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Renkami dalyviai3 fazė
- Rochester Clinical Research, Rochester
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Renkami dalyviai3 fazė
- University of Rochester, Rochester
Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
Renkami dalyviaiStebimasis tyrimas
- University of Rochester Medical Center, Rochester
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Eastman Institute for Oral Health, University of Rochester, Rochester
Nutukimas tyrimai kituose miestuose
- Houston, TX43 tyrimai
- Chicago, IL41 tyrimas
- New York City, NY40 tyrimai
- San Antonio, TX40 tyrimai
- Washington, DC33 tyrimai
- Orlando, FL31 tyrimas
- Dallas, TX30 tyrimai
- Boston, MA28 tyrimai
- Las Vegas, NV27 tyrimai
- Miami, FL27 tyrimai
- Baltimore, MD25 tyrimai
- Jacksonville, FL25 tyrimai
Kiti tyrimai Rochester
- Ūmi mieloidinė leukemija16 tyrimai
- Plaučių vėžys15 tyrimai
- Krūties vėžys15 tyrimai
- Vėžys (visų tipų)14 tyrimai
- Nedidelinių ląstelių plaučių vėžys13 tyrimai
- Antsvoris13 tyrimai
- Prostatos vėžys10 tyrimai
- Kartotinė mieloma8 tyrimai
- Metastatinis vėžys8 tyrimai
- Kasos vėžys7 tyrimai
- Miotoninė distrofija7 tyrimai
- Šlapimo pūslės vėžys7 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.